GXO Logistics has been appointed by NHS England to manage the supply and distribution of Faecal Immunochemical Test (FIT) home testing kits for the national bowel cancer screening program. This partnership supports NHS England's goal to make cancer screening more accessible and convenient, aiding early detection and prevention. GXO will collaborate with partners MAST and RDi to ensure efficient delivery and laboratory support. This move highlights GXO's growing role in healthcare logistics and aligns with NHS plans to shift care towards community settings.
The global automotive microcontrollers market is projected to grow from USD 15.49 billion in 2025 to USD 34.31 billion by 2035, at a CAGR of 8.28%. Growth is fueled by increasing adoption of advanced driver-assistance systems (ADAS), vehicle electrif...
NYDIG projects Bitcoin might fall to $38,000-$39,000 by October 2026 if the current 2025-26 market decline matches the depth of the 2022 bear market. Bitcoin is currently trading near $64,500, down about 30% this year and roughly 50% below its Octobe...
PepsiCo is rated a strong buy due to its attractive combination of dividend yield, earnings growth, and undervaluation. The company is projected to achieve a forward compound annual growth rate (CAGR) between 13.7% and 18.2%, supported by dividend in...
The XRP Ledger (XRPL) has exceeded 8 million activated accounts, marking significant growth driven by institutional interest and AI integration. Originally built for fast cross-border payments, XRPL now supports tokenization of real-world assets, dec...
Ora Banda Mining Ltd (ASX:OBM) melaporkan rekor produksi emas pada kuartal Juni 2026, mencapai 39.552 ounce, sehingga total produksi setahun penuh menjadi 140.949 ounce. Perusahaan mengakhiri Juni dengan kas A$267,7 juta dan total likuiditas A$468 ju...
